AI-powered Brain-Computer Interfaces: Transforming neurological recovery from science fiction to clinical reality

by top100admin | Dec 31, 2025 | AIMEDENT Journal Vol 1:1

In the rapidly advancing landscape of medical technology, few innovations capture the clinical and public imagination as profoundly as Brain-Computer Interfaces (BCIs). Once a concept confined to science fiction, BCIs are now a clinical reality, emerging as a transformative modality for patients with severe neurological impairments. These sophisticated systems establish a direct communication pathway between the brain and an external device, translating neural signals into commands that can restore lost motor and communicative functions. As we transition from investigational research to tangible clinical application, it is imperative for clinicians, scientists, and policymakers to assess the evidence critically, navigate the complex implementation challenges, and steer the ethical trajectory of this powerful technology.

At its core, a BCI decodes intended movements from neural ensemble activity in the motor cortex, translating multi-unit spike patterns into kinematic parameters for an output device.¹ The recent acceleration in BCI development has been catalyzed by the integration of artificial intelligence (AI), particularly machine learning and deep learning algorithms. These computational tools have dramatically enhanced the fidelity and efficiency of neural decoding, enabling the discernment of subtle patterns in complex brain activity with unprecedented precision.² This synergy between computational neuroscience and AI is unlocking clinical applications that were previously deemed unattainable, heralding a new era of restorative neurology.

A new dawn for patients with paralysis: From restoration to recovery

The most immediate and life-altering impact of BCIs is being realized in patients with paralysis resulting from conditions such as spinal cord injury (SCI), amyotrophic lateral sclerosis (ALS), and stroke. For individuals who have lost the ability to move or speak, BCIs offer a gateway to regain autonomy and reconnect with the world. Landmark clinical trials conducted with small cohorts under carefully controlled conditions are demonstrating not just functional restoration, but also evidence of underlying neurological recovery.

A pivotal 2023 study in Nature by Lorach et al. detailed a “digital bridge”—a brain-spine interface that restored communication between the brain and the spinal cord in an individual with chronic tetraplegia. This BSI enabled the participant to stand and walk naturally, with the system’s reliability remaining stable for over a year. The transition to independent home use represents a watershed moment, marking the technology’s maturation from a laboratory-based tool to a viable medical device.³ Remarkably, neurorehabilitation supported by the BCI led to improved neurological recovery, with the participant regaining the ability to walk with crutches even when the interface was switched off.

This progress is mirrored across the field, with the number of individuals with permanent BCI implants growing from approximately 50 in 2020 to 70-80 in 2025. While this accelerating clinical translation is driven by multiple research groups and commercial entities, it is crucial to recognize that these remain small-scale deployments. The strongest results continue to emerge from a handful of specialized centers working with carefully selected participants under controlled task conditions.

The computational engine: AI’s role in decoding neural intent

The sophistication of modern BCIs is inextricably linked to advancements in AI. The brain’s electrical signals are inherently noisy and complex, subject to drift over time as electrodes shift position and tissue responds to chronic implantation. Machine learning models, particularly deep neural networks such as Recurrent Neural Networks (RNNs) and Long Short-Term Memory (LSTM) networks, are exceptionally adept at identifying meaningful patterns within this neural variability.⁷ More recently, Transformer-based architectures and self-supervised learning approaches have emerged as state-of-the-art methods for neural decoding, offering improved performance and reduced training data requirements. These AI “co-pilots” learn to associate specific patterns of brain activity with a user’s intended actions. Furthermore, advances in transfer learning and domain adaptation have reduced within-session calibration time from hours to 15-30 minutes in many systems. However, cross-session and cross-task transfer remain active areas of research.⁸

Modern BCIs increasingly employ closed-loop adaptive decoders that continuously update based on user feedback and changing neural patterns. These systems integrate multi-modal signals – combining neural recordings with eye tracking or residual muscle activity – to achieve more robust and reliable control, particularly in real-world environments outside the laboratory.

Systematic reviews have confirmed the superiority of deep learning approaches for enhancing the accuracy of neural decoding in specific, well-defined tasks.² However, it is crucial to distinguish between BCI modalities and their real-world applicability. While non-invasive EEG-based systems achieve motor imagery classification accuracies around 85%,⁹ invasive intracortical systems consistently demonstrate performance exceeding 95% for discrete classification tasks (e.g., cursor selection, menu navigation) in laboratory settings, though continuous trajectory control typically achieves 70-85% accuracy.⁴ As these AI models become more integrated into clinical devices, addressing the “black box” problem through explainable AI (XAI) will be critical for regulatory approval and clinical trust. It is important to note that models demonstrating impressive results in controlled research environments may require substantial adaptation when deployed across different tasks, environments, or individual users.

Navigating the regulatory and ethical frontier

As with any transformative medical technology, the path from laboratory to widespread clinical adoption is governed by rigorous regulatory oversight and complex ethical considerations. In the U.S., high-performance BCIs are designated as Class III medical devices and require the most stringent Premarket Approval (PMA) pathway from the FDA. To accelerate this process, many BCI developers have received Breakthrough Device Designation, which provides for a more collaborative and prioritized review. The FDA’s 2021 draft guidance on implanted BCI devices, supplemented by workshops on adaptive trial designs, provides a clear framework for developers.¹⁰ However, this must be complemented by robust post-market surveillance to monitor long-term safety and signal stability. In this area, international regulatory bodies, such as the European Union (under its Medical Device Regulation), are also establishing stringent requirements. Emerging regulatory considerations include cybersecurity requirements for wireless implantable BCIs, the use of real-world evidence (RWE) for post-market surveillance, and the development of international standards through IEEE, ISO, and ASTM working groups to ensure device safety and interoperability.

Beyond regulatory approval, the deployment of BCIs raises profound ethical questions. The ability to decode neural signals brings concerns about mental privacy and cognitive liberty to the forefront. The unique challenge of ensuring informed consent—when a device might decode thoughts a user did not consciously intend to share—demands novel ethical and legal safeguards. Frameworks such as the OECD Recommendation on Responsible Innovation in Neurotechnology and the Neurorights Foundation’s proposed legal protections are vital starting points.¹¹ Critical questions of neural data governance remain unresolved: Who owns the neural data generated by these devices? How long should it be retained? What restrictions should govern secondary use for research or commercial purposes? The IEEE P2976 working group on neural data privacy is developing standards to address these questions, but comprehensive legal frameworks are still emerging.

Issues of equity and access are also paramount. The specter of “neurocolonialism”—where technologies developed in high-income nations are deployed in low-resource settings in an extractive manner—is a critical challenge. For example, collecting neural data from vulnerable populations for analysis and commercialization elsewhere, without equitable benefit-sharing, would perpetuate digital colonialism in the neurotechnology domain.

Within high-income nations, equity challenges persist. Geographic disparities in access to specialized neurosurgical centers, insurance coverage variations, and the substantial out-of-pocket costs for experimental therapies create barriers that disproportionately affect rural and socioeconomically disadvantaged populations. Moreover, the disability rights community has raised important questions about the framing of BCIs as ‘cures’ versus tools for accommodation, emphasizing the principle of ‘Nothing About Us Without Us’ in technology development.

The future is clinical: From approval to access

Despite the challenges, the future of Brain-Computer Interfaces is no longer a distant prospect; it is an emerging clinical reality for specific patient populations. The convergence of neuroscience, AI, and medicine is creating a powerful new therapeutic toolkit for some of the most devastating neurological conditions. Based on current regulatory trajectories, the first commercial approvals for narrowly defined indications—such as severe paralysis with communication impairment—are anticipated by 2027-2028, with broader but still clinically focused adoption by 2030-2032. However, FDA approval is only the first step. Widespread clinical access will depend on establishing clear reimbursement pathways with Medicare, Medicaid, and private insurers – a critical health economics challenge that the field must address proactively.

However, scaling from clinical trials to widespread deployment faces substantial practical barriers. Manufacturing must transition from research-grade, hand-assembled devices to commercial-grade production with stringent quality control. Neurosurgical capacity is limited—specialized training programs are needed to prepare surgeons for these novel procedures. Device longevity is typically 5-10 years, necessitating replacement surgeries and upgrade pathways, with adverse event rates, including infection, remaining below 5% in recent trials. The total cost of care—including surgery ($100,000-$200,000), devices, follow-up visits, and maintenance—raises critical cost-effectiveness questions that payers will scrutinize.

It is essential to maintain realistic expectations. BCIs are not poised to replace keyboards, smartphones, or conventional assistive technologies for the general population in the foreseeable future. Instead, their transformative potential lies in serving individuals for whom conventional interfaces are inaccessible—those who are locked-in, severely paralyzed, or have lost the ability to communicate through traditional means. For this population, a reliable, high-bandwidth neural communication channel is not a lifestyle enhancement but a profound restoration of agency and connection to the world.

From the patient perspective, early adopters report profound improvements in quality of life and sense of agency. However, the daily reality includes calibration sessions, periodic clinical visits for system maintenance, and the psychological adjustment to living with an implanted device. Understanding and supporting the lived experience of BCI users—not just the technical performance—will be essential for successful long-term deployment.

For physicians, surgeons, and allied health professionals, the rise of BCIs signals a need to engage with and understand this rapidly advancing field. By fostering a collaborative ecosystem built on evidence-based practice, rigorous scientific validation, and a steadfast commitment to ethical principles, we can ensure that the mind’s new frontier benefits all of humanity – less magic, more medicine.

References

1. Donoghue, J. P. (2002). Connecting cortex to machines: recent advances in brain interfaces. Nature Neuroscience, 5(Suppl), 1085-1088.
2. Saeidi, M., Karwowski, W., Farahani, F. V., Fiok, K., & Taiar, R. (2021). Neural Decoding of EEG Signals with Machine Learning: A Systematic Review. Brain Sciences, 11(11), 1525.
3. Lorach, H., Galvez, A., Spagnolo, V., et al. (2023). Walking naturally after spinal cord injury using a brain-spine interface. Nature, 618, 126-133.
4. Willett, F. R., Avansino, D. T., Hochberg, L. R., Henderson, J. M., & Shenoy, K. V. (2021). High-performance brain-to-text communication via handwriting. Nature, 593, 249-254.
5. ClinicalTrials.gov. (2024). A Feasibility Study to Assess the Safety and Efficacy of the Synchron Stentrode System for Motor Enablement in Patients With Severe Paralysis (COMMAND). NCT05035823.
6. STAT News. (2025, November 20). FDA approves Paradromics’ brain-computer interface trial for speech restoration.
7. Livezey, J. A., & Kording, K. P. (2021). Deep learning approaches for neural decoding across tasks and time. Briefings in Bioinformatics, 22(2), 1577-1591.
8. Glaser, J. I., Benjamin, A. S., Farhoodi, R., & Kording, K. P. (2020). The Roles of Supervised Machine Learning in Systems Neuroscience. Progress in Neurobiology, 194, 101826.
9. Das, A., et al. (2025). Enhanced EEG signal classification in brain-computer interface systems by leveraging advanced machine learning and deep learning. Scientific Reports.
10. U.S. Food and Drug Administration. (2021, May 20). Implanted Brain-Computer Interface (BCI) Devices for Patients with Paralysis or Amputation: Non-Clinical Testing and Clinical Considerations.
11. OECD. (2019). Recommendation of the Council on Responsible Innovation in Neurotechnology. OECD Legal Instruments.

About the author

Dr. Srikanth Mahankali is a leading expert in the implementation of medical AI and policy. As CEO of Shree Advisory & Consulting and a member of the NSF/MITRE AI Workforce Machine Learning Working Group, he shaped national AI strategy while driving responsible innovation in healthcare.

Dental ethics in the age of artificial intelligence: Global perspectives and the Saudi experience

by top100admin | Dec 31, 2025 | AIMEDENT Journal Vol 1:1

Abstract

Artificial intelligence (AI) is rapidly transforming dentistry through applications in radiographic interpretation, caries detection, orthodontic planning, and digital smile design. Yet, these advances raise profound ethical questions regarding patient privacy, algorithmic bias, accountability, and transparency. This article examines the ethical foundations of Dental AI, drawing on global frameworks and emerging debates, while highlighting the pioneering Saudi experience in publishing the first national-level AI ethics charter for healthcare. The Saudi framework, issued in 2022 by the Saudi Data and Artificial Intelligence Authority (SDAIA) and the Ministry of Health, integrates international best practices with Islamic bioethical values, emphasizing patient-centricity, privacy, transparency, equity, accountability, and sustainability. Case studies demonstrate the real-world consequences of ethical lapses, from radiographic misinterpretation to orthodontic bias and data-sharing concerns. Particular attention is given to federated learning as a privacy-preserving solution that enables collaboration without compromising data security. Finally, future directions are discussed, including the integration of ethics into dental curricula and the need for international consensus through bodies such as the FDI World Dental Federation. By embedding ethics at the core, Dental AI can remain a tool in service of humanity, not the reverse.

Introduction

Artificial intelligence (AI) is transforming dentistry with unprecedented speed and depth. From diagnostic imaging and caries detection to orthodontic planning, implantology, and digital smile design, AI has begun to redefine the relationship between technology, clinician, and patient. Studies have shown that AI can reach or even exceed expert-level performance in radiographic interpretation, pathology detection, and predictive analytics for oral diseases. Despite this promise, profound ethical questions emerge: How can patient data be protected? How can we prevent algorithmic bias that could disadvantage vulnerable populations? Who bears responsibility when AI fails? These are not peripheral questions—they are central to the legitimacy and long-term adoption of AI in dentistry.

This article examines the broad ethical landscape of AI in dental practice, drawing on global guidelines and bioethical debates, and then focuses on the pioneering Saudi experience in publishing the first national-level ethical framework for AI in healthcare. This initiative represents a historic milestone for the region and provides valuable lessons for global dentistry, including implications for the diverse dental communities across the United States. Moreover, AI’s integration into dentistry is not limited to diagnostics. Robotics for oral surgery, AI-powered scheduling systems, smart dental chairs, and patient engagement chatbots are redefining dental care delivery. With these advances, ethical issues become intertwined with practical realities—making the discussion of Dental AI ethics not merely theoretical, but a pressing matter for clinicians, policymakers, and technologists alike.

Core ethical challenges in dental AI

The integration of AI into dental practice raises several key ethical challenges that must be addressed:

• Patient privacy and data security – Reliance on imaging and records raises concerns around consent, secondary use, and vulnerability to cyberattacks. For instance, dental radiographs stored in cloud servers may be vulnerable to unauthorized access if robust encryption protocols are not followed. Ethical dental AI must therefore incorporate state-of-the-art cybersecurity solutions while ensuring compliance with local and international regulations such as GDPR and HIPAA.
• Algorithmic bias and fairness – Datasets may underrepresent certain populations, creating disparities in diagnostic accuracy. This challenge is universal, affecting diverse populations whether in the Middle East, North America, or other regions globally.
• Transparency and explainability – The ‘black box’ nature of AI requires explainable AI (XAI) for trust and adoption across all healthcare systems.
• Accountability and liability – Clarity is needed in defining responsibility when AI outputs cause harm, regardless of jurisdiction.
• Human oversight and autonomy – The dentist must remain the final decision-maker in all clinical contexts.
• Professional integrity – Preventing over-reliance on AI and preserving clinical reasoning skills remains essential for maintaining professional standards globally.

Global ethical frameworks for AI in healthcare

International organizations have addressed these issues through guidelines:

• WHO (2021) emphasized accountability, inclusiveness, and sustainability.
• European Commission (2019) proposed ‘Trustworthy AI.’
• ADA and various dental AI associations have begun adapting general AI principles into dentistry.

Yet, most frameworks remain broad and not specific to dental practice, highlighting the need for more specialized guidance. The Saudi experience: A pioneering ethical charter.

Saudi Arabia, aligned with Vision 2030, has positioned itself as a global leader in AI governance. In 2022, the Saudi Data and Artificial Intelligence Authority (SDAIA), in collaboration with the Ministry of Health, published the ‘AI Ethics in Healthcare Charter’—the first national framework of its kind in the Middle East. The Charter integrates international best practices with Islamic bioethical principles such as justice, beneficence, and respect for human dignity.

The process of drafting the Charter involved multi-stakeholder collaboration—including ethicists, engineers, clinicians, legal scholars, and policymakers. Workshops and consultations ensured that the framework was both technically rigorous and socially legitimate. Importantly, dentistry was identified as a priority field given its rapid digitization and the unique sensitivity of dental data, such as facial images and 3D intraoral scans.

Key principles of the Saudi framework

1. Patient-centricity – Prioritizing safety and dignity in all AI applications.
2. Privacy and security – Ensuring robust data protection within national jurisdiction while enabling beneficial uses.
3. Transparency – Requiring explainable and auditable AI systems that practitioners can understand and trust.
4. Equity – Ensuring fair access across urban and rural regions, addressing disparities in healthcare delivery.
5. Accountability – Clarifying roles and responsibilities of developers, clinicians, and regulators.
6. Sustainability – Aligning AI adoption with long-term healthcare goals and resource allocation.

Historical and cultural context of dental ethics in AI

Ethics in medicine and dentistry has a long history rooted in cultural, religious, and professional codes. From the Hippocratic Oath to Islamic medical ethics pioneered by Ibn Sina and Al-Razi, the central principles of beneficence, non-maleficence, autonomy, and justice remain relevant. In modern dentistry, these principles intersect with new technological paradigms: algorithms, machine learning models, and robotic systems. Saudi Arabia’s approach is distinctive in that it explicitly connects its AI ethics framework to Islamic values, positioning the Kingdom at the crossroads of tradition and innovation while offering universal principles applicable across cultures.

Federated learning: An ethical enabler

One of the most promising approaches to address privacy and fairness challenges in Dental AI is Federated Learning. Instead of centralizing sensitive dental data, federated learning allows multiple clinics or hospitals to train a shared AI model locally. The model parameters are then aggregated centrally without transferring raw patient data. This method, first proposed by Konečný et al. (2016), enables cross-institutional collaboration while safeguarding privacy.

In the Saudi context, federated learning aligns perfectly with the AI Ethics Charter. It allows hospitals from Riyadh to Jeddah, and from Dammam to NEOM, to contribute to the development of robust AI tools without compromising confidentiality. Such a system not only protects privacy but also ensures representation of diverse patient populations, thereby reducing algorithmic bias.

Additionally, federated learning supports continual model improvement while respecting local regulations. For example, dental schools across Saudi Arabia could collectively train AI systems for caries detection, benefiting from data diversity without compromising privacy. This collaborative approach also aligns with global trends towards distributed, privacy-preserving AI and offers a model that other countries and regions can adapt to their own contexts.

Case studies in dental AI ethics

Several real-world scenarios highlight the importance of ethical principles in practice:

• Radiographic misinterpretation: An AI model misclassified a periapical lesion, leading to unnecessary endodontic treatment. The case raised questions about liability between the dentist and software developer, demonstrating the need for clear accountability frameworks.
• Bias in orthodontic predictions: A machine learning model trained primarily on European patients underperformed when used on Saudi adolescents, underlining the need for diverse datasets that represent global populations.
• Data sharing concerns: A multinational dental imaging project faced resistance from patients who feared their facial scans could be misused beyond healthcare. Federated learning was introduced as a solution, demonstrating practical applications of privacy-preserving technologies.

Implications for dental AI worldwide

The Saudi ethical framework, combined with federated learning, offers a replicable model for the global community:

• It serves as a blueprint for other nations seeking culturally grounded AI ethics frameworks that respect local values while maintaining universal ethical principles.
• It encourages dental associations worldwide to issue Dental AI-specific ethical guidelines adapted to their regulatory and cultural contexts.
• It strengthens international collaborations in AI development without violating privacy regulations, enabling global knowledge sharing while protecting patient data.

The Saudi experience demonstrates that comprehensive ethical frameworks can be developed that honor cultural and religious traditions while embracing technological innovation. This model has particular relevance for diverse societies worldwide, including the multicultural communities served by dental professionals globally.

Future directions

Looking ahead, Dental AI ethics will increasingly require dynamic governance structures. Rapid innovations such as generative AI, 3D printing with AI-based design, and integration of genomic data pose new ethical dilemmas. Saudi Arabia’s framework offers a strong foundation, but continuous updates will be essential as technology evolves.

Professional dental associations should develop AI ethics curricula for dental education, ensuring that future dentists are not only competent in using AI tools but also conscious of their ethical implications. International collaboration, perhaps through the FDI World Dental Federation, could lead to a global consensus on Dental AI ethics, harmonizing diverse cultural and regulatory perspectives while building on pioneering efforts like the Saudi framework.

The integration of ethics education into dental curricula worldwide will be essential for preparing the next generation of practitioners. This education should include both theoretical foundations and practical case studies, drawing on experiences from various cultural and regulatory contexts.

Conclusion

Ethics in Dental AI is not an afterthought—it is the foundation of trust between patients, clinicians, and technology. Saudi Arabia’s pioneering step in publishing the first AI ethics framework in healthcare demonstrates that cultural values and modern bioethics can converge successfully. By embracing privacy-preserving technologies such as federated learning, the Kingdom sets a global precedent for ethical AI in dentistry.

The Saudi experience offers valuable lessons for the international dental community, demonstrating that comprehensive ethical frameworks can be developed that honor local values while establishing universal principles. As dental professionals worldwide grapple with similar challenges, the Saudi model provides a roadmap for integrating ethics into AI implementation.

As dentistry enters an era where AI systems may detect caries, design smiles, and even guide surgeries, the guiding question remains: Will AI remain a servant of humanity, or will humanity become its servant? Saudi Arabia’s experience suggests that ethics can ensure the former, providing a model that the global dental community can adapt and build upon.

The path forward requires continued international collaboration, sharing of best practices, and commitment to placing patient welfare and professional integrity at the center of all AI development and implementation efforts.

References

1. Topol E. Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Basic Books; 2019.
2. Char DS, Shah NH, Magnus D. Implementing Machine Learning in Health Care — Addressing Ethical Challenges. N Engl J Med. 2018;378:981–983.
3. Doshi-Velez F, Kim B. Towards a rigorous science of interpretable machine learning. arXiv preprint arXiv:1702.08608. 2017.
4. World Health Organization. Ethics and governance of artificial intelligence for health: WHO guidance. Geneva: WHO; 2021.
5. European Commission. Ethics Guidelines for Trustworthy AI. Brussels; 2019.
6. Saudi Data and Artificial Intelligence Authority (SDAIA). Charter of AI Ethics in Healthcare. Riyadh; 2022.
7. Konečný J, McMahan HB, Ramage D, Richtárik P. Federated optimization: Distributed optimization beyond the datacenter. arXiv preprint arXiv:1511.03575. 2016.
8. American Dental Association. AI in Dentistry: Current and Future Applications. ADA White Paper; 2023.

About the author

Dr. Ameed Khalid Abdul-Hamid is an Iraqi–British dental surgeon and academic researcher, internationally recognized for his contributions to artificial intelligence in dentistry and healthcare. He holds advanced qualifications from the University of Baghdad and the University of London, and is a Fellow of the Royal College of Surgeons (UK). Dr. Abdul-Hamid serves as Chairman of the Arab Organisation for Artificial Intelligence in Healthcare and Chairman of the Saudi-British Medical Forum (London). His research focuses on AI-enabled diagnostics, digital health systems, and the ethical, responsible integration of artificial intelligence in clinical care. In 2025, his work in dental artificial intelligence was published in the British Dental Journal, and he is a recipient of the Alan Turing Award in Dental Artificial Intelligence.